Caffyns PLC
LSE:CFYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Caffyns PLC
LSE:CFYN
|
UK |
|
E
|
Exmar NV
F:1EX
|
BE |
|
IperionX Limited
ASX:IPX
|
AU |
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
A
|
Azenta Inc
F:BA3
|
US |
|
D
|
Defiance Silver Corp
F:D4E
|
CA |
|
T
|
T&D Holdings Inc
DUS:TZ6
|
JP |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
M
|
Melbana Energy Ltd
F:MU9
|
AU |
|
E
|
Emerald Resources NL
OTC:EOGSF
|
AU |
Intrinsic Value
Is CFYN undervalued or overvalued?
See the intrinsic value estimate for
Caffyns PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CFYN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CFYN’s past valuations and how the stock performed after similar periods.
The intrinsic value for
Caffyns PLC (CFYN) under the Base Case is hidden GBX.
Compared with the current market price of 500 GBX, the stock appears hidden.